Innova Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
6,176
+12
+0.2% +$2.58K 0.64% 40
2026
Q1
$1.34M Sell
6,164
-6
-0.1% -$1.33K 0.63% 34
2025
Q4
$1.41M Buy
6,170
+227
+4% +$51.7K 0.71% 38
2025
Q3
$1.38M Buy
5,943
+1,001
+20% +$204K 0.74% 33
2025
Q2
$917K Buy
4,942
+47
+1% +$8.73K 0.54% 36
2025
Q1
$1.03M Buy
4,895
+108
+2% +$21K 0.64% 30
2024
Q4
$851K Buy
4,787
+3,281
+218% +$603K 0.54% 35
2024
Q3
$297K Sell
1,506
-3,215
-68% -$600K 0.24% 59
2024
Q2
$810K Buy
4,721
+81
+2% +$13.4K 0.58% 39
2024
Q1
$845K Buy
4,640
+21
+0.5% +$3.62K 0.65% 32
2023
Q4
$716K Buy
4,619
+76
+2% +$11.1K 0.62% 28
2023
Q3
$677K Buy
4,543
+471
+12% +$69.1K 0.61% 24
2023
Q2
$549K Sell
4,072
-249
-6% -$36.5K 0.47% 31
2023
Q1
$689K Hold
4,321
0.6% 23
2022
Q4
$698K Buy
4,321
+51
+1% +$7.82K 0.61% 27
2022
Q3
$573K Sell
4,270
-99
-2% -$14.2K 0.52% 23
2022
Q2
$669K Buy
4,369
+161
+4% +$24.6K 0.56% 20
2022
Q1
$682K Sell
4,208
-29
-0.7% -$4.21K 0.49% 28
2021
Q4
$574K Hold
4,237
0.41% 32
2021
Q3
$457K Sell
4,237
-59
-1% -$6.74K 0.36% 37
2021
Q2
$484K Sell
4,296
-439
-9% -$49.4K 0.38% 38
2021
Q1
$512K Buy
4,735
+41
+0.9% +$4.38K 0.44% 35
2020
Q4
$503K Buy
+4,694
New +$451K 0.47% 35

Other funds holding ABBV

Innova Wealth Partners's ABBV Position: Q2 2026 in Review

Innova Wealth Partners increased its AbbVie (ABBV) stake by 0.19% in Q2 2026, buying an estimated $2.58K and bringing the position to 6,176 shares worth $1.55M. The position accounts for 0.64% of the portfolio, ranked #40.

Innova Wealth Partners first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Innova Wealth Partners held 6,176 shares of AbbVie worth $1.55M as of Q2 2026.
  • Innova Wealth Partners bought 12 AbbVie shares in Q2 2026, an estimated $2.58K.
  • AbbVie made up 0.64% of Innova Wealth Partners's portfolio in Q2 2026, its #40 holding.
  • Innova Wealth Partners first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Innova Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.